info@trade-jp.net
menu
News / Blog
New Year Holidays 2024 / 2025
03/12/2024
Please pay attention that due to local holidays in Japan (End of Year holidays – Dec 27th to Jan 5th) we shall operate as follows:
ORDER
Catalog
| Product Code |
|
| Availability | 5 |
| Price | USD 249.00 |
| Qty |
Atomoxetine tablets 25 mg for attention-deficit/hyperactivity disorder (ADHD, Strattera)
Product Code :
Availability : 5
USD 249.00
Are Atomoxetine tablets 25 mg effective for the treatment of attention-deficit/hyperactivity disorder (ADHD, Strattera)?
Atomoxetine tablets offer a targeted approach to managing attention-deficit/hyperactivity disorder (ADHD) symptoms, providing relief for individuals struggling with inattention, hyperactivity, or impulsiveness. As a key element in ADHD treatment, these tablets function by regulating neurotransmitters responsible for transmitting information between nerve cells in the brain. This mechanism of action is crucial in addressing the core symptoms associated with ADHD, making atomoxetine tablets a valuable option for those in need of effective management.
One of the notable advantages of atomoxetine tablets is their suitability for a broad age range. Whether for adults grappling with ADHD or children as young as 6 years old, these tablets provide a versatile treatment option that can cater to varying needs across different age groups. This versatility enhances accessibility and ensures that individuals of all ages can benefit from effective ADHD management.
Moreover, the effectiveness of atomoxetine tablets is well-supported by extensive research and clinical trials. Numerous studies have validated the efficacy of the active ingredients in alleviating ADHD symptoms, underscoring the reliability of this treatment option. For instance, in a comprehensive study titled “Safety and Tolerability of Atomoxetine Hydrochloride in a Long-Term, Placebo-Controlled Randomized Withdrawal Study in European and Non-European Adults with Attention-Deficit/ Hyperactivity Disorder”, researchers observed positive outcomes in over 2000 patients across 18 countries. The study demonstrated that atomoxetine exhibited an acceptable safety profile in adults with ADHD, with sustained efficacy even after 1 year of treatment. Importantly, no clinically meaningful safety-related rebound effects were noted following abrupt discontinuation after 24 weeks of treatment, further affirming the favorable risk-benefit profile of atomoxetine tablets.
In conclusion, atomoxetine tablets represent a reliable and effective option for individuals seeking to manage ADHD symptoms. With their ability to target core symptoms and their demonstrated efficacy across diverse age groups, these tablets offer a comprehensive solution for those navigating the challenges of ADHD. Supported by robust research findings, atomoxetine tablets stand as a cornerstone in ADHD treatment, providing hope and relief for countless individuals worldwide.
Package details: 140 tablets
Dosage and administration:
For patients under 18 years old: start this medication at a daily total of 0.5 mg/kg as atomoxetine, then increase to 0.8 mg/kg daily, and subsequently up to 1.2 mg/kg. Maintenance should fall within the range of 1.2 to 1.8 mg/kg per day. Adjustments should occur weekly or longer. In all cases, the medicine should be taken in 2 separate doses daily. Dosage may be tailored based on symptoms, but should not exceed 1.8 mg/kg or 120 mg daily, whichever is lower.
For patients 18 years or older: begin with a total daily dose of 40 mg as atomoxetine, increasing to 80 mg daily, with maintenance ranging from 80 to 120 mg daily. Up to 80 mg, increments should happen weekly or longer, then at intervals of 2 weeks or longer beyond 80 mg. Administer as a single daily dose or divided into two. Dosage adjustments can be made based on symptoms, but should not exceed 120 mg per day.
Each preparation contains 25 mg of atomoxetine. Do not crush or grind the tablet; swallow whole to avoid eye irritation. If particles come into contact with your eyes, rinse with water immediately and seek medical advice. If particles touch your skin, wash thoroughly with water.
Active components: Atomoxetine hydrochloride
Therapeutic effect: the treatment of attention-deficit/hyperactivity disorder (ADHD)
Contraindications and precautions: The medication could induce drowsiness or dizziness. Refrain from driving or operating hazardous machinery following its administration. Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use.
Do not use in the following cases:
- pregnant or breastfeeding,
- cardiovascular disorder,
- pheochromocytoma or a history of it,
- angle-closure glaucoma.
There are no reviews for this product.
Write a review
Rating
Bad
Good
News
New Year Holidays 2024 / 2025
03/12/2024
Please pay attention that due to local holidays in Japan (End of Year holidays – Dec 27th to Jan 5th) we shall operate as follows:
ORDER ACCEPTANCE
We stop accepting orders during holidays from Dec 26th to Jan 3rd. Website will not allow orders, please order on Jan 3rd, evening (Japanese time)
No suppliers will operate this week so changes in shipping time / price / product availability are possible. Product may become unavailable as well.
Please pay attention: orders paid after Dec 15th may be shipped after Jan 6th because Japan Post and courier services will not operate during Holidays. If you pay before we are 99% likely to ship before holidays. If you pay after make sure you can wait as delays are possible due to end of year holidays. Some suppliers stop working before Dec 26th, please pay attention!
SUPPORT TEAM and PAYMENT CONFIRMATIONS
Will not work on Dec 31st , Jan 1st Jan 2nd - No email of any urgency will be replied. Thank you for understanding. Do not send sseveral emails during this period.
We shall resume support work on Jan 3rd, but we may need time to reply.
We shall continue to work as usual starting Jan 6th.
Pay attention that payments may be affected by your local holidays in your country / country of payment systems (during Christmas holidays and New Year holidays).
SHIPIPNG - DELAYS till January 10th.
We stop shipping all orders from Dec 28th to Jan 6th. Japan Post and courtier services will not work during this period so there are possible delays for some orders (mainly injections and some tablets) paid after Dec 15th
We shall resume normal work from Monday 6th.